Ovarian cancer: epigenetics, drug resistance, and progression
2021 · Cancer Cell International · 81 citations
https://doi.org/10.1186/s12935-021-02136-y
X
Xipeng Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
898
Citations
16
h-index
22
i10-index
Xipeng Wang is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Cancer-related molecular mechanisms research & Adenosine and Purinergic Signaling & Cancer Genomics and Diagnostics. The author has an h-index of 16, co-authored 41 publications.
ORCID: 0009-0002-6804-0829Papers by this author
worksCEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer
2023 · Journal of Translational Medicine · 35 citations
https://doi.org/10.1186/s12967-023-04136-0
Distinct RNA transcriptome patterns are potentially associated with angiogenesis in Tie2-expressing monocytes
2015 · Gene · 33 citations
https://doi.org/10.1016/j.gene.2015.12.065
Markers and Mechanisms of Deterioration Reactions in Dairy Products
2023 · Food Engineering Reviews · 14 citations
https://doi.org/10.1007/s12393-023-09331-9
PD-1/PD-L1 axis is involved in the interaction between microglial polarization and glioma
2024 · International Immunopharmacology · 14 citations
https://doi.org/10.1016/j.intimp.2024.112074
Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherapy)
2025 · BMC Cancer · 4 citations
https://doi.org/10.1186/s12885-025-13589-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat